- indicates presentation available
The increase of antimicrobial resistance (AMR) in the environment is an increasingly acknowledged major concern for healthcare providers; this is a public health concern for both maintaining the efficacy of existing medication and potential intervention mechanisms for infection control, improving facilities' best practice. Reducing this release of AMR genetic material into the wider environment, from where it could feed back into human health via the wider food chain, is an important aspect of generic AMR abatement that goes beyond healthcare interventions and brings together health, wastewater and building services professions.
Speaker Professor Ole Pahl, Professor of Environmental Technology - Glasgow Caledonian University
An environmental engineer with a background in waste water treatment, nutrient removal from waste, and atmospheric emissions during waste (-water) treatment. His more recent work has been concentrated on aquatic pharmaceutical micropollutant assessment and removal. Much of his micropollutants work is in close collaboration not only with organisations from across Europe, but also with colleagues across various disciplines.
A look at the pharmaceutical industry's perspectives on pharmaceuticals in the environment and proposed actions to manage the issue.
Bengt has an MSc-degree in Chemical Engineering and a PhD-degree in Polymer Chemistry from the Royal Institute of Technology in Stockholm, Sweden. He has been working in the pharmaceutical industry since 1994, focusing sustainability related matters. He works 50% at Pfizer Sweden and 50% at the Swedish pharmaceutical industry association LIF. Since Jan 2014 he is co-chair of EFPIA's (the European Federation of Pharmaceutical Industries and Associations) task force on pharmaceuticals in the environment (PIE TF), today a joint initiative between the three industry associations EFPIA, Medicines for Europe, and AESGP.
Presentation: Pharmaceuticals in the environment: Options for action
By discussing the available options, Dr. Anette Küster aims to motivate delegates to choose one or more of the presented options for actions and increase the determination to implement such actions.
Author of 35 national and international papers and reports, Dr Küster studied biology and marine sciences in Marburg, Bangor (Wales) and Rostock (Germany) where she received her PhD. Between 2002-2006 she was a Senior Scientist at Helmholtz Centre for Environmental Research (UFZ), Leipzig, with special interest in plant physiology and ecotoxicology. In 2013/14 she was delegated to the National Oceanic and Atmospheric Administration in Charleston, US. Dr Küster is a listed expert within the EU Commission since 2012. She coordinated and/or was involved in a number of national and international projects such as the EU project PHARMAS, Ecological and human health risk assessments of antibiotics and anticancer drugs found in the environment.
Website by Studio Beam 2016